络病理论对寒地小儿肺系疾病的指导  

Guidance of Collateral Theory on Pulmonary Diseases in Children in Cold Region

作　　者：关洋洋[1] 刘璐佳 刘丽丽[2] 石庆雪 王有鹏[3] GUAN Yangyang;LIU Lujia;LIU Lili;SHI Qingxue;WANG Youpeng(Heilongjiang University of Traditional Chinese Medicine,Harbin 150040,Heilongjiang,China;Harbin University of Science and Technology,Harbin 150001,Heilongjiang,China;The Second Affiliated Hospital of Heilongjiang University of Traditional Chinese,Harbin 150001,Heilongjiang,China)

机构地区：[1]黑龙江中医药大学,黑龙江哈尔滨150040 [2]哈尔滨理工大学,黑龙江哈尔滨150001 [3]黑龙江中医药大学附属第二医院,黑龙江哈尔滨150001

出　　处：《辽宁中医杂志》2021年第4期68-70,共3页Liaoning Journal of Traditional Chinese Medicine

基　　金：国家自然科学基金(81874485);黑龙江中医药大学科研基金(201832)。

摘　　要：络病理论已形成完整的学术体系,目前络病理论指导儿科疾病的论述较少,对具体疾病的发生发展规律认识欠清晰。试将络病理论运用到儿科难治性肺系疾病中,结合寒地地域特点及小儿生理病理特点,分析、探讨咳嗽变异性哮喘、肺炎支原体肺炎、新型冠状病毒肺炎(COVID-19)、腺样体肥大的中医病机,以指导临床用药,提高临床疗效,并为络病理论体系的发展增砖添瓦。The collateral theory has formed a complete academic system.At present,there are few discussions on the guidance of collateraltheory to pediatric diseases,and the understanding of the occurrence and development of specific diseases is not clear.It tried to apply the collateraltheoryto the intractable pulmonary diseases in childrenand combine the characteristics of cold region and children's physiology and pathology to analyze and explore the pathogenesis of cough variant asthma,mycoplasma pneumoniae pneumonia,coronavirus disease 2019(COVID-19)and adenoid hypertrophy in traditional Chinese medicine,so as to guide the clinical medication,improve the clinical efficacy,and contribute to the development of collateraltheory system.

关 键 词：络病 寒地 咳嗽变异性哮喘 新型冠状病毒(COVID-19)肺炎 腺样体肥大 

分 类 号：R224[医药卫生—中医基础理论]